» Articles » PMID: 37649893

Advances in the Roles of Glycyrrhizic Acid in Cancer Therapy

Overview
Journal Front Pharmacol
Date 2023 Aug 31
PMID 37649893
Authors
Affiliations
Soon will be listed here.
Abstract

Since the first 70 years of reporting cancer chemotherapy, malignant tumors have been the second most common cause of death in children and adults. Currently, the commonly used anti-cancer methods include surgery, chemotherapy, radiotherapy, and immunotherapy. Although these treatment methods could alleviate cancer, they lead to different forms of side effects and have no particularly significant effect on prolonging the patients' life span. Glycyrrhizic acid (GL), a native Chinese herbal extract, has a wide range of pharmacological effects, such as anti-cancer, anti-inflammatory, antioxidant, and immune regulation. In this review, the anti-cancer effects and mechanisms of GL are summarized in various cancers. The inhibition of GL on chemotherapy-induced side effects, including hepatotoxicity, nephrotoxicity, genotoxicity, neurotoxicity and pulmonary toxicity, is highlighted. Therefore, GL may be a promising and ideal drug for cancer therapy.

Citing Articles

Glycyrrhizin enhances the antitumor activity of cisplatin in non‑small cell lung cancer cells by influencing DNA damage and apoptosis.

Tong Z, Wang Z, Jiang J, Fu W, Hu S Oncol Lett. 2025; 29(4):207.

PMID: 40070780 PMC: 11894513. DOI: 10.3892/ol.2025.14954.


Oral administration of glycyrrhizic acid with intramuscular injection of foot-and-mouth disease vaccine enhances the adaptive immune system.

Shin S, Kim H, Ko M, Park S, Park J, Kim S Front Microbiol. 2025; 16:1502630.

PMID: 40046304 PMC: 11880001. DOI: 10.3389/fmicb.2025.1502630.


De novo assembly of the mitochondrial genome of Glycyrrhiza glabra and identification of two types of homologous recombination configurations caused by repeat sequences.

Zhou G, Qin M, Liu X, Qi Y, Ou X, Tang M BMC Genomics. 2025; 26(1):13.

PMID: 39762760 PMC: 11705715. DOI: 10.1186/s12864-024-11190-5.


Targeted Delivery of Celastrol by GA-Modified Liposomal Calcium Carbonate Nanoparticles to Enhance Antitumor Efficacy Against Breast Cancer.

Zhang W, Li J, Yue L, Ji C Pharmaceutics. 2024; 16(11).

PMID: 39598506 PMC: 11597737. DOI: 10.3390/pharmaceutics16111382.


Neuroprotective Potential of Glycyrrhizic Acid in Ischemic Stroke: Mechanisms and Therapeutic Prospects.

Li Y, Wu J, Du F, Tang T, Lim J, Karuppiah T Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598404 PMC: 11597102. DOI: 10.3390/ph17111493.


References
1.
Bi X, Yang L, Lin Y, Deng W, Jiang T, Zhang L . Efficacy and Safety of Glycyrrhizic Acid in Treatment of Autoimmune Hepatitis. Am J Chin Med. 2023; 51(2):391-405. DOI: 10.1142/S0192415X23500209. View

2.
Zhou J, Wink M . Reversal of Multidrug Resistance in Human Colon Cancer and Human Leukemia Cells by Three Plant Extracts and Their Major Secondary Metabolites. Medicines (Basel). 2018; 5(4). PMC: 6313689. DOI: 10.3390/medicines5040123. View

3.
Rastogi V, Yadav P, Bhattacharya S, Mishra A, Verma N, Verma A . Carbon nanotubes: an emerging drug carrier for targeting cancer cells. J Drug Deliv. 2014; 2014:670815. PMC: 4020363. DOI: 10.1155/2014/670815. View

4.
Karimi P, Islami F, Anandasabapathy S, Freedman N, Kamangar F . Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014; 23(5):700-13. PMC: 4019373. DOI: 10.1158/1055-9965.EPI-13-1057. View

5.
Li M, Xiang L, Li Y . Efficacy and safety of compound glycyrrhizin in the patients with vitiligo: a systematic review and meta-analysis. Expert Rev Clin Pharmacol. 2023; 16(6):601-611. DOI: 10.1080/17512433.2023.2213887. View